Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans. - Packard, C.J.; Taskinen, M.R.; Björnson, E.; Matikainen, N.; Söderlund, S.; Andersson, L.; Adiels, M.; Borén, J. (Atherosclerosis (00219150), 2025)